|
- 2018
Topical Imiquimod 5% as a Treatment Option in Solitary Facial KeratoacanthomaKeywords: Solitary keratoacanthoma, treatment, Imiquimod Abstract: Keratoacanthoma (KA) is a rapidly growing epithelial tumour with histopathologic and clinical features similar to squamous cell carcinoma (SCC) and a certain tendency toward spontaneous regression
|